Patent Assignment
Reel/Frame 042635/0511
Change of Name
Recorded: 2017-05-31
Pages: 4
Assignor
RIB-X PHARMACEUTICALS, INC.
Executed: 2013-10-07
Assignee
MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301, NEW HAVEN, CONNECTICUT, 06511-6663
Covered Property
(1)
Triazole Compounds And Methods Of Making And Using The Same
Application:
15/597,701 →
Publication:
US 2018/0094016
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 31, 2017
From: BHATTACHARJEE, ASHOKE; KANYO, ZOLTAN F.; SHERER, EDWARD C.
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 042543/0309 →
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest
Aug 22, 2019
From: MELINTA THERAPEUTICS, INC.; MELINTA SUBSIDIARY CORP.
To: BIOVERSYS AG
Reel/Frame 050128/0253 →